Edwards Lifesciences Corp (EW) has been subjected to numerous investigations and lawsuits, with various law firms reminding investors of deadlines for filing as lead plaintiff. The pressure on the company's stock performance has increased amid these legal developments. Renowned TV personality Jim Cramer questioned if EW is set for a comeback, while Bank of America upgraded the stock to a 'Buy'. Daniel J. Lippis sold 2,500 shares of EW weakening investor confidence. At the same time, Franklin Resources Inc. and State Street Corp have been increasing their holdings. The company is under scrutiny for its weak earnings guidance. Despite this, its Q3 results showed strong growth TMTT sales, though overall company performance lacks a strong financial backing. EW's fundamental strength is being questioned even as it outlines its vision for future growth. It is essential for investors to closely track these developments when considering their investment decisions for EW.
Edwards Lifesciences Corp EW News Analytics from Tue, 24 Sep 2024 07:00:00 GMT to Fri, 20 Dec 2024 21:04:08 GMT - Rating -2 - Innovation -1 - Information 3 - Rumor 1
